Why Enzene Biosciences?
We are a CDMO and biosimilar developer driven by the vision to positively impact the global healthcare landscape by bringing trusted and affordable medicines to market at speed.
About Enzene
Committed to innovation, we have revolutionized the field of continuous manufacturing through our proprietary EnzeneX™ technology, that enables us to significantly reduce the cost of producing complex biologics and monoclonal antibodies (mAbs).
Through a passionately progressive approach, our cutting-edge services and productive pipeline of biosimilars are designed to cater to your project’s every need.
Why partner with Enzene Biosciences?
31 projects across all stages, modalities and geographies (US & EU)
11 projects in the late and commercialization stages
12 months to go from gene-to-phase 1 for complex proteins
8 weeks onboarding time (vs an average of 4-5 months)
Up to 50% lower carbon footprint with EnzeneX™
10x higher productivity and improved quality for complex proteins with EnzeneX™
What makes us stand out?
Our continuous manufacturing platform
A platform that pushes your project further
Unlocking higher yields across a range of biologics at significantly lower costs to you, our patented continuous bioprocess manufacturing platform represents the pinnacle of our ongoing commitment to innovation.
Enzene Biosciences is one of the only proven providers of EnzeneX™, a technology that harnesses the power of intensified perfusion using alternate tangential flow (ATF) and automated multi-column chromatography to achieve continuous production of biologics.
Designed for efficiency and cost-effectiveness, EnzeneX™ enables uninterrupted loading and processing of materials, delivering superior product quality and manufacturing outcomes.
Regulatory expertise
We know where you want to be and how to get you there.
Discover how our intricate knowledge of global and local regulatory requirements helps us achieve swift approvals for your products across your target markets.
Join the revolution
Fueled by our continuous innovation and armed with EnzeneX™, our fully-integrated CDMO solutions and our biosimilars pipeline are designed to help bring your biologics innovations to life.